Piplani S - Search Results

1

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.

Li L, Honda-Okubo Y, Huang Y, Jang H, Carlock MA, Baldwin J, Piplani S, Bebin-Blackwell AG, Forgacs D, Sakamoto K, Stella A, Turville S, Chataway T, Colella A, Triccas J, Ross TM, Petrovsky N. Li L, et al. Among authors: piplani s. Vaccine. 2021 Sep 24;39(40):5940-5953. doi: 10.1016/j.vaccine.2021.07.087. Epub 2021 Aug 3. Vaccine. 2021. PMID: 34420786 Free PMC article.

2

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant.

Kaushik D, Dhingra S, Patil MT, Piplani S, Khanna V, Honda-Okubo Y, Li L, Fung J, Sakala IG, Salunke DB, Petrovsky N. Kaushik D, et al. Among authors: piplani s. Hum Vaccin Immunother. 2020 Aug 2;16(8):1989-1996. doi: 10.1080/21645515.2019.1710409. Epub 2020 Apr 16. Hum Vaccin Immunother. 2020. PMID: 32298200 Free PMC article.

3

TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects.

Kaur A, Kaushik D, Piplani S, Mehta SK, Petrovsky N, Salunke DB. Kaur A, et al. Among authors: piplani s. J Med Chem. 2021 Jan 14;64(1):233-278. doi: 10.1021/acs.jmedchem.0c01627. Epub 2020 Dec 21. J Med Chem. 2021. PMID: 33346636 Review.

4

Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent.

Kaushik D, Granato JT, Macedo GC, Dib PRB, Piplani S, Fung J, da Silva AD, Coimbra ES, Petrovsky N, Salunke DB. Kaushik D, et al. Among authors: piplani s. J Pharm Pharmacol. 2021 Aug 12;73(9):1180-1190. doi: 10.1093/jpp/rgab063. J Pharm Pharmacol. 2021. PMID: 33940589 Free PMC article.

5

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.

Piplani S, Singh PK, Winkler DA, Petrovsky N. Piplani S, et al. Sci Rep. 2021 Jun 24;11(1):13063. doi: 10.1038/s41598-021-92388-5. Sci Rep. 2021. PMID: 34168168 Free PMC article.

6

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.

Piplani S, Singh PK, Winkler DA, Petrovsky N. Piplani S, et al. Sci Rep. 2021 Sep 14;11(1):18610. doi: 10.1038/s41598-021-98366-1. Sci Rep. 2021. PMID: 34521997 Free PMC article. No abstract available.

7

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective.

Baldwin J, Piplani S, Sakala IG, Honda-Okubo Y, Li L, Petrovsky N. Baldwin J, et al. Among authors: piplani s. Bioanalysis. 2021 Dec;13(24):1805-1826. doi: 10.4155/bio-2021-0096. Epub 2021 Oct 14. Bioanalysis. 2021. PMID: 34645288 Free PMC article.

8

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies.

Piplani S, Singh PK, Winkler DA, Petrovsky N. Piplani S, et al. Mol Biomed. 2021;2(1):28. doi: 10.1186/s43556-021-00050-3. Epub 2021 Sep 20. Mol Biomed. 2021. PMID: 34766004 Free PMC article.

9

Artificial Intelligence in Vaccine and Drug Design.

Thomas S, Abraham A, Baldwin J, Piplani S, Petrovsky N. Thomas S, et al. Among authors: piplani s. Methods Mol Biol. 2022;2410:131-146. doi: 10.1007/978-1-0716-1884-4_6. Methods Mol Biol. 2022. PMID: 34914045

10

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M^pro) as Potential COVID-19 Therapies.

Piplani S, Singh P, Petrovsky N, Winkler DA. Piplani S, et al. Front Mol Biosci. 2022 Mar 14;9:781039. doi: 10.3389/fmolb.2022.781039. eCollection 2022. Front Mol Biosci. 2022. PMID: 35359601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters